These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 20357604)
41. Bioterrorism watch. They don't call it bioterror for nothing: fear is the foe when anthrax spores are found within hospital walls. Evans G ED Manag; 2002 Jun; 14(6):suppl 1-3. PubMed ID: 12046239 [No Abstract] [Full Text] [Related]
45. Index case of fatal inhalational anthrax due to bioterrorism in the United States. Bush LM; Abrams BH; Beall A; Johnson CC N Engl J Med; 2001 Nov; 345(22):1607-10. PubMed ID: 11704685 [No Abstract] [Full Text] [Related]
46. Medical counterbioterrorism: the response to provide anthrax prophylaxis to New York City US Postal Service employees. Partridge R; Alexander J; Lawrence T; Suner S Ann Emerg Med; 2003 Apr; 41(4):441-6. PubMed ID: 12658240 [TBL] [Abstract][Full Text] [Related]
47. Serious adverse events among participants in the Centers for Disease Control and Prevention's Anthrax Vaccine and Antimicrobial Availability Program for persons at risk for bioterrorism-related inhalational anthrax. Tierney BC; Martin SW; Franzke LH; Marano N; Reissman DB; Louchart RD; Goff JA; Rosenstein NE; Sever JL; McNeil MM; Clin Infect Dis; 2003 Oct; 37(7):905-11. PubMed ID: 13130401 [TBL] [Abstract][Full Text] [Related]
48. [Bacillus anthracis: causative agent of anthrax]. Boutiba-Ben Boubaker I; Ben Redjeb S Tunis Med; 2001 Dec; 79(12):642-6. PubMed ID: 11892436 [TBL] [Abstract][Full Text] [Related]
53. Gram-positive rod surveillance for early anthrax detection. Begier EM; Barrett NL; Mshar PA; Johnson DG; Hadler JL; Emerg Infect Dis; 2005 Sep; 11(9):1483-6. PubMed ID: 16229790 [TBL] [Abstract][Full Text] [Related]
54. From the Centers for Disease Control and Prevention. Public health dispatch: update: cutaneous anthrax in a laboratory worker-Texas, 2002. JAMA; 2002 Jul 24-31; 288(4):444. PubMed ID: 12141318 [No Abstract] [Full Text] [Related]
55. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Jernigan JA; Stephens DS; Ashford DA; Omenaca C; Topiel MS; Galbraith M; Tapper M; Fisk TL; Zaki S; Popovic T; Meyer RF; Quinn CP; Harper SA; Fridkin SK; Sejvar JJ; Shepard CW; McConnell M; Guarner J; Shieh WJ; Malecki JM; Gerberding JL; Hughes JM; Perkins BA; Emerg Infect Dis; 2001; 7(6):933-44. PubMed ID: 11747719 [TBL] [Abstract][Full Text] [Related]
56. Increased detection of rickettsialpox in a New York City hospital following the anthrax outbreak of 2001: use of immunohistochemistry for the rapid confirmation of cases in an era of bioterrorism. Koss T; Carter EL; Grossman ME; Silvers DN; Rabinowitz AD; Singleton J; Zaki SR; Paddock CD Arch Dermatol; 2003 Dec; 139(12):1545-52. PubMed ID: 14676069 [TBL] [Abstract][Full Text] [Related]
57. Animal models of human anthrax: the Quest for the Holy Grail. Goossens PL Mol Aspects Med; 2009 Dec; 30(6):467-80. PubMed ID: 19665473 [TBL] [Abstract][Full Text] [Related]
60. Fear of bioterrorism and implications for public health preparedness. Dworkin MS; Ma X; Golash RG Emerg Infect Dis; 2003 Apr; 9(4):503-5. PubMed ID: 12702237 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]